thyroid cancer cancer develops tissues thyroid disease cells grow abnormally potential spread parts symptoms include swelling lump cancer also occur thyroid spread locations case classified thyroid risk factors include radiation exposure young age enlarged thyroid family history four main types papillary thyroid cancer follicular thyroid cancer medullary thyroid cancer anaplastic thyroid diagnosis often based ultrasound fine needle screening people without symptoms normal risk disease recommended treatment options may include surgery radiation therapy including radioactive iodine chemotherapy thyroid hormone targeted therapy watchful surgery may involve removing part fiveyear survival rates united globally million people thyroid new cases commonly diagnosed ages women affected often asian descent commonly higher rate mortality among filipino rates increased last decades believed due better resulted often first symptom thyroid cancer nodule thyroid region however adults small nodules thyroids typically nodules found sometimes first sign enlarged lymph node later symptoms present pain anterior region neck changes voice due involvement recurrent laryngeal thyroid cancer usually found euthyroid patient symptoms hyperthyroidism hypothyroidism may associated large metastatic welldifferentiated tumor thyroid nodules particular concern found age presentation benign nodules age less likely thus potential malignancy far greatercitation needed thyroid cancers thought related number environmental genetic predisposing factors significant uncertainty remains regarding environmental exposure ionizing radiation natural background sources artificial sources suspected play significant role significantly increased rates thyroid cancer occur exposed mantlefield radiation lymphoma exposed following fukushima kyshtym nuclear thyroiditis thyroid diseases also predispose thyroid genetic causes include multiple endocrine neoplasia type markedly increases rates particularly rarer medullary form thyroid nodule found physical examination referral endocrinologist thyroidologist may occur commonly ultrasound performed confirm presence nodule assess status whole gland ultrasound results may report tirads tirads score categorize risk measurement thyroid stimulating hormone free andor total triiodothyronine thyroxine levels antithyroid antibodies help decide functional thyroid disease hashimotos thyroiditis present known cause benign nodular thyroid scan performed often conjunction radioactive iodine uptake test may used determine whether nodule hot may help make decision whether perform biopsy measurement calcitonin necessary exclude presence medullary thyroid cancer finally achieve definitive diagnosis deciding treatment fine needle aspiration cytology test may performed reported according bethesda diagnosis understand potential spread disease follow monitoring surgery whole body radioactive iodine scan may adults without symptoms screening thyroid cancer thyroid cancers classified according histopathological variants distinguished distribution various subtypes may show regional variation follicular papillary types together classified differentiated thyroid types favorable prognosis medullary undifferentiated cancer staging process determining extent development cancer tnm staging system usually used classify stages cancers stage thyroid cancer stage thyroid cancer stage thyroid cancer stage thyroid cancer stage thyroid cancer stage thyroid cancer stage thyroid cancer stage thyroid cancer stage thyroid cancer detection differentiated thyroid cancer metastases may detected performing fullbody scintigraphy using thyroid cancer spread directly via lymphatics blood direct spread occurs infiltration surrounding tissues tumor infiltrates infrahyoid muscles trachea oesophagus recurrent laryngeal nerve carotid sheath etc tumor becomes fixed anaplastic carcinoma spreads mostly direct spread papillary carcinoma spreads least lymphatic spread common papillary carcinoma cervical lymph nodes become palpable papillary carcinoma even primary tumor unpalpable deep cervical nodes pretracheal prelaryngeal paratracheal groups lymph nodes often affected lymph node affected usually side location tumor blood spread also possible thyroid cancers especially follicular anaplastic carcinoma tumor emboli angioinvasion lungs end long bones skull vertebrae affected pulsating metastases occur increased thyroidectomy dissection central neck compartment initial step treatment thyroid cancer majority thyroidpreserving operations may applied cases thyroid cancer exhibits low biological aggressiveness eg welldifferentiated cancer evidence lymphnode metastases low index major genetic alterations like braf mutations retptc rearrangements mutations etc patients younger diagnosis welldifferentiated thyroid cancer eg papillary thyroid cancer established suspected fna surgery indicated whereas watchful waiting strategy recommended evidencebased watchful waiting reduces overdiagnosis overtreatment thyroid cancer among old radioactive used people papillary follicular thyroid cancer ablation residual thyroid tissue surgery treatment thyroid patients medullary anaplastic hurthlecell cancers benefit external irradiation may used cancer unresectable recurs resection relieve pain bone sorafenib lenvatinib approved advanced metastatic thyroid numerous agents phase ii iii clinical post surgical monitoring recurrence metastasis may include routine ultrasound ct scans fdgpetct radioactive iodine whole body scans routine laboratory blood tests changes thyrogolubin thyroglobuilin antibodies calcitonin depending variant thyroid prognosis thyroid cancer related type cancer stage time diagnosis common form thyroid cancer papillary overall prognosis excellent indeed increased incidence papillary thyroid carcinoma recent years likely related increased earlier diagnosis one look trend earlier diagnosis two ways first many cancers small likely develop aggressive malignancies second perspective earlier diagnosis removes cancers time likely spread beyond thyroid gland thereby improving longterm outcome patient consensus exists present whether trend toward earlier diagnosis beneficial unnecessary argument early diagnosis treatment based logic many small thyroid cancers mostly papillary grow metastasize view holds overwhelming majority thyroid cancers overdiagnosed never cause symptoms illness death patient even nothing ever done cancer including overdiagnosed cases skews statistics lumping clinically significant cases apparently harmless thyroid cancer incredibly common autopsy studies people dying causes showing onethird older adults technically thyroid cancer causing detecting nodules might cancerous easy simply feeling throat contributes level overdiagnosis benign noncancerous nodules frequently coexist thyroid cancer sometimes benign nodule discovered surgery uncovers incidental small thyroid cancer increasingly small thyroid nodules discovered incidental findings imaging ct scan mri ultrasound performed another purpose people accidentally discovered symptomfree thyroid cancers ever symptoms treatment patients potential cause harm help thyroid cancer three times common women men according european overall relative survival rate thyroid cancer females table highlights challenges decision making prognostication thyroid cancer general agreement exists stage ii papillary follicular medullary cancer good prognoses evaluating small thyroid cancer determine ones grow metastasize possible result diagnosis thyroid cancer established commonly fine needle aspiration total thyroidectomy likely performed drive earlier diagnosis also manifested european continent use serum calcitonin measurements patients goiter identify patients early abnormalities parafollicular calcitoninproducing cells within thyroid gland multiple studies demonstrated finding elevated serum calcitonin associated finding medullary thyroid carcinoma high cases europe threshold thyroid surgery lower united states elaborate strategy incorporates serum calcitonin measurements stimulatory tests calcitonin incorporated decision perform thyroidectomy thyroid experts united states looking data part incorporated calcitonin testing routine part evaluations thereby eliminating large number thyroidectomies consequent morbidity european thyroid community focused prevention metastasis small medullary thyroid carcinomas north american thyroid community focused prevention complications associated thyroidectomy see american thyroid association guidelines demonstrated table individuals stage iii iv disease significant risk dying thyroid cancer many present widely metastatic disease equal number evolve years decades stage ii disease physicians manage thyroid cancer stage recognize small percentage patients lowrisk thyroid cancer progress metastatic disease improvements made thyroid cancer treatment recent years identification molecular dna abnormalities led development therapies target molecular defects first agents negotiate approval process vandetanib tyrosine kinase inhibitor targets ret protooncogene two subtypes vascular endothelial growth factor receptor epidermal growth factor compounds investigation likely make approval process differentiated thyroid carcinoma strategies evolving use selected types targeted therapy increase radioactive iodine uptake papillary thyroid carcinomas lost ability concentrate iodide strategy would make possible use radioactive iodine therapy treat resistant thyroid cancers targeted therapies evaluated making life extension possible next years stage iii iv thyroid cancer prognosis better younger people older prognosis depends mainly type cancer cancer stage thyroid cancer resulted deaths globally obesity may associated higher incidence thyroid cancer relationship remains subject much thyroid cancer accounts less cancer cases deaths uk around people diagnosed thyroid cancer uk around people died disease however south korea thyroid cancer prevalent cancer accounted new cancer cases httpsenwikipediaorgwikithyroidcancer